(Q37934708)

25 August 2017

title

Absorption and metabolism of glycosidic sweeteners of stevia mixture and their aglycone, steviol, in rats and humans (English)

1 reference

25 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738193

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0278-6915(03)00039-5

31 December 2023

author name string

Eriko Koyama

1

1 reference

25 August 2017

Norifumi Sakai

2

1 reference

25 August 2017

Yuji Ohori

3

1 reference

25 August 2017

Ken Kitazawa

4

1 reference

25 August 2017

Osamu Izawa

5

1 reference

25 August 2017

Kunio Kakegawa

6

1 reference

25 August 2017

Akiharu Fujino

7

1 reference

25 August 2017

Michio Ui

8

1 reference

25 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12738193

31 December 2023

publication date

1 June 2003

1 reference

25 August 2017

number of pages

9

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0278691503000395?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0278-6915(03)00039-5

https://api.elsevier.com/content/article/PII:S0278691503000395?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0278-6915(03)00039-5

Food and Chemical Toxicology

31 December 2023

published in

1 reference

25 August 2017

volume

41

1 reference

25 August 2017

issue

6

1 reference

25 August 2017

page(s)

875-883

1 reference

Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Pharmacokinetic studies of 131I-stevioside and its metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Intestinal absorption and metabolism of xenobiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Mass spectral analysis of some derivatives and in vitro metabolites of steviol, the aglycone of the natural sweeteners, stevioside, rebaudioside A, and rubusoside.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Stevioside and related sweet diterpenoid glycosides

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

In vitro metabolism of the glycosidic sweeteners, stevia mixture and enzymatically modified stevia in human intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Evaluation of the genotoxicity of stevioside and steviol using six in vitro and one in vivo mutagenicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Regionally-targeted mutagenesis by metabolically-activated steviol: DNA sequence analysis of steviol-induced mutants of guanine phosphoribosyltransferase (gpt) gene of Salmonella typhimurium TM677.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Metabolically activated steviol, the aglycone of stevioside, is mutagenic

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Potential sweetening agents of plant origin. III. Organoleptic evaluation of Stevia leaf herbarium samples for sweetness

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Acute toxicity of stevioside, a natural sweetener, and its metabolite, steviol, in several animal species.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Assessment of the carcinogenicity of stevioside in F344 rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

The use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surface

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Intestinal degradation and absorption of the glycosidic sweeteners stevioside and rebaudioside A

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Chronic oral toxicity and carcinogenicity study of stevioside in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Drug absorption from the gastrointestinal tract and immunity: the mechanism of the decreased absorption of salicylic acid during systemic anaphylaxis. I.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-6915%2803%2900039-5

7 January 2021

Subchronic oral toxicity study of stevioside in F344 rats

3

1 reference

https://api.crossref.org/works/10.1016/S0278-6915(03)00039-5

31 December 2023

Identifiers

1 reference

25 August 2017

1 reference